Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.18B |
| 2 |
Medtronic
MDT
|
+$2.06B |
| 3 |
Microsoft
MSFT
|
+$1.61B |
| 4 |
Procter & Gamble
PG
|
+$1.47B |
| 5 |
UBS Group
UBS
|
+$1.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.42B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$2.34B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$930M |
| 4 |
Apple
AAPL
|
+$637M |
| 5 |
SWY
SAFEWAY INC
SWY
|
+$620M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.67% |
| 2 | Technology | 13.6% |
| 3 | Financials | 13.57% |
| 4 | Industrials | 10.71% |
| 5 | Consumer Discretionary | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
2076
DELISTED
Array Biopharma Inc
ARRY
| $35.6M | ﹤0.01% |
4,832,090
+444,821
| +10% | +$3.17M |
|
|
SAAS
2077
DELISTED
inContact, Inc.
SAAS
| $35.6M | ﹤0.01% |
3,264,267
+42,027
| +1% | +$423K |
|
2078
SK Telecom
SKM
$13.2B
| $35.6M | ﹤0.01% |
816,529
-157,758
| -16% | -$7.31M |
|
2079
Walker & Dunlop
WD
$1.53B
| $35.4M | ﹤0.01% |
1,998,713
+641,098
| +47% | +$10.9M |
|
|
SGMO
2080
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $35.4M | ﹤0.01% |
2,259,797
+114,411
| +5% | +$1.77M |
|
2081
Movado Group
MOV
$841M
| $35.4M | ﹤0.01% |
1,242,334
+52,513
| +4% | +$1.32M |
|
2082
Mercury Systems
MRCY
$6.52B
| $35.4M | ﹤0.01% |
2,276,730
+151,345
| +7% | +$2.39M |
|
|
DCOM
2083
DELISTED
Dime Community Bancshares
DCOM
| $35.4M | ﹤0.01% |
2,197,897
+110,525
| +5% | +$1.72M |
|
|
CZR
2084
DELISTED
Caesars Entertainment Corporation
CZR
| $35.3M | ﹤0.01% |
3,356,812
+166,970
| +5% | +$1.85M |
|
|
UCB
2085
United Community Banks
UCB
$4.28B
| $35.3M | ﹤0.01% |
1,872,026
+141,517
| +8% | +$2.61M |
|
|
RSO
2086
DELISTED
Resource Capital Corp.
RSO
| $35.3M | ﹤0.01% |
1,944,461
+90,837
| +5% | +$1.74M |
|
2087
Tredegar Corp
TG
$310M
| $35.3M | ﹤0.01% |
1,754,388
+62,121
| +4% | +$1.3M |
|
|
LNW
2088
DELISTED
Light & Wonder
LNW
| $35.2M | ﹤0.01% |
3,366,548
+122,361
| +4% | +$1.54M |
|
|
ZSPH
2089
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $35.1M | ﹤0.01% |
834,585
+476,844
| +133% | +$21.8M |
|
2090
Renasant Corp
RNST
$3.91B
| $35.1M | ﹤0.01% |
1,167,223
+54,703
| +5% | +$1.54M |
|
|
PMC
2091
DELISTED
PharMerica Corporation
PMC
| $34.8M | ﹤0.01% |
1,235,693
-96,550
| -7% | -$2.4M |
|
2092
American Public Education
APEI
$940M
| $34.8M | ﹤0.01% |
1,159,223
+52,422
| +5% | +$1.75M |
|
2093
E.W. Scripps
SSP
$304M
| $34.7M | ﹤0.01% |
1,375,848
+58,268
| +4% | +$1.17M |
|
2094
Spok Holdings
SPOK
$241M
| $34.5M | ﹤0.01% |
1,799,726
+65,884
| +4% | +$1.21M |
|
|
CBPX
2095
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $34.5M | ﹤0.01% |
1,525,714
+442,146
| +41% | +$8.14M |
|
2096
Standard Motor Products
SMP
$911M
| $34.4M | ﹤0.01% |
814,388
+39,181
| +5% | +$1.53M |
|
|
NWLIA
2097
DELISTED
NATL WESTN LIFE INS CO CL A
NWLIA
| $34.3M | ﹤0.01% |
134,927
+4,723
| +4% | +$1.2M |
|
2098
Acacia Research
ACTG
$470M
| $34.3M | ﹤0.01% |
3,201,340
+176,872
| +6% | +$2.31M |
|
|
MYCC
2099
DELISTED
ClubCorp Holdings, Inc.
MYCC
| $34.3M | ﹤0.01% |
1,769,275
+122,582
| +7% | +$2.21M |
|
2100
TETRA Technologies
TTI
$1.26B
| $34.2M | ﹤0.01% |
5,528,814
+191,439
| +4% | +$1.05M |
|
Similar funds
Vanguard Group's Q1 2015 Portfolio in Review
As of Q1 2015, Vanguard Group held 4,228 positions worth $1.47T, up 6.2% from $1.39T the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Vanguard Group deployed $66B of net new capital in Q1 2015, opening 181 new positions and adding to 3,456 existing holdings. Its largest new stake was UBS Group: 57,940,325 shares worth $1.09B.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $637M trimmed.
- Vanguard Group's largest Q1 2015 buy was UBS Group: 57,940,325 shares worth $1.09B.
- Vanguard Group added most to Allergan plc in Q1 2015, an estimated $2.18B increase.
- Vanguard Group's biggest Q1 2015 reduction was Apple, cutting an estimated $637M.
- Vanguard Group fully exited Allergan Inc in Q1 2015, selling an estimated $3.42B.
- Vanguard Group's ten largest holdings make up 12% of its $1.47T portfolio in Q1 2015.
- Vanguard Group opened 181 new positions and closed 75 in Q1 2015.
- Vanguard Group's portfolio value rose 6.2% quarter-over-quarter to $1.47T.
Based on Vanguard Group's 13F filing for Q1 2015, filed 14 May 2015.